semaglutide at weight loss clinic Medical in Berlin, MD Personalized Weight Management Support in

Compounded semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist which may be used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)

Increasing clinical adoption of GLP-1 receptor agonists for glycemic control and weight management is accelerating demand across developed and emerging healthcare systems

Deeper pigmentation may need more

Yes, GLP-1 therapy may support improved blood sugar regulation, making it beneficial for individuals with prediabetes or certain metabolic concerns, under physician supervision